SPDR S&P Biotech ETF (NYSEARCA:XBI) Holdings Trimmed by LGL Partners LLC

LGL Partners LLC lowered its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 0.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 22,813 shares of the exchange traded fund’s stock after selling 138 shares during the quarter. LGL Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $2,037,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the company. EPG Wealth Management LLC boosted its position in shares of SPDR S&P Biotech ETF by 152.7% in the 3rd quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock valued at $34,000 after purchasing an additional 278 shares during the period. Tennessee Valley Asset Management Partners acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $44,000. Wetzel Investment Advisors Inc. acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $45,000. Sheets Smith Wealth Management acquired a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at $55,000. Finally, Life Planning Partners Inc acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $64,000.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI traded down $0.42 during midday trading on Tuesday, reaching $85.10. The company had a trading volume of 5,200,159 shares, compared to its average volume of 11,624,016. The company has a fifty day simple moving average of $92.54 and a two-hundred day simple moving average of $84.94. The firm has a market cap of $6.61 billion, a price-to-earnings ratio of 11.47 and a beta of 1.08. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.